Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

A Phase I Study of a New Tuberculosis (TB) Vaccine, MVA85A, in Healthy Volunteers With HIV

This study has been completed.
Sponsor:
Collaborator:
Centre Hospitalier Universitaire Le Dantec, Dakar, Senegal
Information provided by:
University of Oxford
ClinicalTrials.gov Identifier:
NCT00731471
First received: August 6, 2008
Last updated: March 25, 2011
Last verified: March 2011